
浏览全部资源
扫码关注微信
1.云南省第一人民医院心内科,昆明 650000
2.云南省工人疗养院超声科,昆明 650000
3.云南中医药大学第二附属医院老年病科,昆明 650000
马成东,Email:619014463@qq.com, 研究方向:心血管疾病基础与临床研究。
杞红梅,Email:1005019950@qq.com。
收稿:2025-07-07,
修回:2025-09-09,
录用:2025-09-24,
网络出版:2025-11-25,
移动端阅览
马成东,张宏,马仲杰等.HCM患者运动康复的研究与进展[J].重庆医科大学学报,
Ma Chengdong,Zhang Hong,Ma Zhongjie,et al.Research and advances in exercise rehabilitation for patients with hypertrophic cardiomyopathy[J].Journal of Chongqing Medical University,
马成东,张宏,马仲杰等.HCM患者运动康复的研究与进展[J].重庆医科大学学报, DOI:10.13406/j.cnki.cyxb..
Ma Chengdong,Zhang Hong,Ma Zhongjie,et al.Research and advances in exercise rehabilitation for patients with hypertrophic cardiomyopathy[J].Journal of Chongqing Medical University, DOI:10.13406/j.cnki.cyxb..
肥厚型心肌病(hypertrophic cardiomyopathy,HCM)是一种常见的常染色体显性遗传性疾病,主要特征为左室壁的异常增厚,其发病率约为1∶500~1∶200
[
1
1
]
。心脏性猝死(sudden cardiac Death,SCD)已成为HCM患者面临的最为严重的临床后果,也是运动员猝死的主要原因,相关研究表明,在年轻运动员的心脏性猝死中,HCM占30%以上,这也导致了一些国家建立了一些适当的参加运动训练的指引。在当前的医学领域,针对HCM患者是否应当增加运动强度的问题,仍然是一个颇具争议的议题。然而,随着2017年《中国成人肥厚型心肌病诊断与治疗指南》
[
2
2
]
发表和2023年《中国成人肥厚型心肌病诊断与治疗指南》
[
3
3
]
相继更新后,这一争议目前已趋于明朗。本文就目前HCM患者运动康复的最新国内外研究与进展作一综述。
Hypertrophic cardiomyopathy(HCM) is a common autosomal dominant genetic disease characterized by abnormal thickening of the left ventricular wall,with an incidence rate of about 1∶500 to 1∶200. Sudden cardiac death(SCD) has become the most serious clinical consequence faced by HCM patients,and it is also the main cause of sudden death in athletes. Related studies have shown that HCM accounts for more than 30% of SCD cases in young athletes,and therefore,some countries have established appropriate guidelines for participating in exercise training. In the current medical field,there are still controversies over whether to increase the intensity of exercise for HCM patients. However,with the release of the Chinese Adult Hypertrophic Cardiomyopathy Diagnosis and Treatment Guidelines in 2017 and the subsequent update of the Chinese Adult Hypertrophic Cardiomyopathy Diagnosis and Treatment Guidelines in 2023,this controversial issue has tended to become clear. This article reviews the latest research and advances in exercise rehabilitation for HCM patients in China and globally.
杜明昭 , 康连鸣 , 宋 雅 . 成人肥厚型心肌病康复和运动管理中国专家共识 [J ] . 中国循环杂志 , 2024 , 39 ( 1 ): 29 - 40 .
Du MZ , Kang LM , Song Y . Chinese expert consensus on rehabilitation and exercise management in adults with hypertrophic cardiomyopathy [J ] . Chin Circ J , 2024 , 39 ( 1 ): 29 - 40 .
中华医学会心血管病学分会中国成人肥厚型心肌病诊断与治疗指南编写组 , 《中华心血管病杂志》编辑委员会 . 中国成人肥厚型心肌病诊断与治疗指南 [J ] . 中华心血管病杂志 , 2017 , 45 ( 12 ): 1015 - 1032 .
The Writing Committee of the Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy in Chinese Adults , under the Chinese Society of Cardiology , Chinese Medical Association , in collaboration with the Editorial Committee of the Chinese Journal of Cardiovascular Diseases . Guidelines for the diagnosis and treatment for Chinese adult patients with hypertrophic cardiomyopathy [J ] . Chinese Journal of Cardiology , 2017 , 45 ( 12 ): 1015 - 1032 .
国家心血管病中心心肌病专科联盟、中国医疗保健国际交流促进会心血管病精准医学分会“中国成人肥厚型心肌病诊断与治疗指南”专家组 . 中国成人肥厚型心肌病诊断与治疗指南2023 [J/OL ] . 中国分子心脏病学杂志 , 2023 : 1 - 35 . ( 2023-02-16 ). https://link.cnki. net/doi/10.16563/j. cnki. 1671-6272.2023.02.001 https://link.cnki.net/doi/10.16563/j.cnki.1671-6272.2023.02.001 .
The Joint Committee of Cardiomyopathy Specialty Alliance,National Center for Cardiovascular Diseases/Cardiovascular Precision Medicine Branch of China International Exchange and Promotive Association . 2023 guideline for diagnosis and treatment of patients with hypertrophic cardiomyopathy [J/OL ] . Mol Cardiol China , 2023 : 1 - 35 . ( 2023-02-16 ). https://link. cnki. net/doi/10.16563/j. cnki. 1671-6272.2023.02.001 https://link.cnki.net/doi/10.16563/j.cnki.1671-6272.2023.02.001 .
Finocchiaro G , Sheikh N , Biagini E , et al . The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy [J ] . Heart Rhythm , 2020 , 17 ( 1 ): 142 - 151 .
熊 思 , 秦 蕾 , 阮 坚 , 等 . 心肌声学造影联合心脏MRI对肥厚性心肌病的诊断价值 [J ] . 临床超声医学杂志 , 2021 , 23 ( 6 ): 445 - 449 .
Xiong S , Qin L , Ruan J , et al . Myocardial contrast echocardiography combined with cardiac MRI in the diagnosis of hypertrophic cardiomyopathy [J ] . J Clin Ultrasound Med , 2021 , 23 ( 6 ): 445 - 449 .
Bhasin D , Sharma A , Sharma YP , et al . Utility of cardiac computed tomography in the diagnosis of apical hypertrophic cardiomyopathy: a case series [J ] . Heart Views , 2024 , 25 ( 2 ): 86 - 91 .
Funabashi N , Akaza S , Shukuya A , et al . Abstract 18374: effective atomic number and electron density number acquired using latest spectral CT enable the differentiation of infarcted myocardium and hypertrophied myocardium from normal myocardium [J ] . Circulation , 2023 , 148 ( Suppl_1 ): A18374 - A18374 .
Aoki S , Takaoka H , Asada K , et al . Abstract 16623: extra-cellular volume fraction analysis on cardiac CT is useful for predicting the prognosis of hypertrophic cardiomyopathy [J ] . Circulation , 2023 , 148 ( Suppl_1 ): A16623 - A16623 .
Khalil M , Benjamin MM , Munir MS , et al . Abstract 12158: left atrial volumes and strain by cardiac magnetic resonance are associated with long term outcomes in patients with hypertrophic cardiomyopathy [J ] . Circulation , 2022 , 146 ( Suppl_1 ): A12158 - A12158.
Han C , Zhou MY , Hu R , et al . Trans-septal myocardial biopsy in hypertrophic cardiomyopathy using the liwen procedure: an introduction of a novel technique [J ] . J Interv Cardiol , 2021 , 2021 : 1905184 .
Shintani Y , Nakayama T , Masaki A , et al . Clinical impact of the pathological quantification of myocardial fibrosis and infiltrating T lymphocytes using an endomyocardial biopsy in patients with hypertrophic cardiomyopathy [J ] . Int J Cardiol , 2022 , 362 : 110 - 117 .
Saleem M , Balla S , Amin MS , et al . Hereditary apolipoprotein A-I-associated cardiac amyloidosis: importance of endomyocardial biopsy when suspicion remains high [J ] . JACC Case Rep , 2021 , 3 ( 7 ): 1032 - 1037 .
Shang EH , Tan HM . Comparison of drug therapy efficacy in patients with hypertrophic cardiomyopathy: a network meta-analysis [J ] . Am J Cardiol , 2024 , 226 : 97 - 107 .
Ma SL , Song L . Research progress on anti-myocardial fibrosis drugs for hypertrophic cardiomyopathy [J ] . Zhonghua Xin Xue Guan Bing Za Zhi , 2024 , 52 ( 12 ): 1452 - 1457 .
Butzner M , Papademetriou E , Potluri R , et al . Differences in healthcare resource use and cost by pharmacotherapy among patients with symptomatic obstructive hypertrophic cardiomyopathy: real-world analysis of claims data [J ] . Am J Cardiovasc Drugs , 2024 , 24 ( 6 ): 801 - 811 .
Mazur M , Braksator W , Popjes E . Hypertrophic cardiomyopathy: from medical treatment to advanced heart failure therapies [J ] . Curr Cardiol Rep , 2024 , 26 ( 9 ): 985 - 994 .
Gaballa A , Jadam S , Desai MY . Promising therapies for adults with symptomatic obstructive hypertrophic cardiomyopathy: 2023 and beyond [J ] . Expert Opin Pharmacother , 2024 , 25 ( 7 ): 915 - 924 .
Hutt E , Desai MY . Medical treatment strategies for hypertrophic cardiomyopathy [J ] . Am J Cardiol , 2024 , 212 S: S33 - S41 .
Zhu M , Reyes KRL , Bilgili G , et al . Medical therapies to improve left ventricular outflow obstruction and diastolic function in hypertrophic cardiomyopathy [J ] . JACC Adv , 2023 , 2 ( 8 ): 100622 .
Desai MY , Owens A , Wang A . Medical therapies for hypertrophic cardiomyopathy: Current state of the art [J ] . Prog Cardiovasc Dis , 2023 , 80 : 32 - 37 .
Rosenzveig A , Garg N , Rao SJ , et al . Current and emerging pharmacotherapy for the management of hypertrophic cardiomyopathy [J ] . Expert Opin Pharmacother , 2023 , 24 ( 12 ): 1349 - 1360 .
李晓艺 , 吴宏祥 , 王若冰 , 等 . 改良Morrow术治疗儿童肥厚型梗阻性心肌病远期疗效的单中心回顾性研究 [J ] . 中国胸心血管外科临床杂志 , 2024 , 31 ( 7 ): 985 - 990 .
Li XY , Wu HX , Wang RB , et al . Long-term effect of modified Morrow surgery on hypertrophic obstructive cardiomyopathy in children: A retrospective study in a single center [J ] . Chin J Clin Thorac Cardiovasc Surg , 2024 , 31 ( 7 ): 985 - 990 .
Subramanian M , Shekar V , Krishnamurthy P , et al . Optimizing diastolic filling by pacing in nonobstructive hypertrophic cardiomyopathy [J ] . Heart Rhythm , 2023 , 20 ( 9 ): 1307 - 1313 .
Lin MX , Huang SF , Huang XY , et al . Left bundle branch pacing improved the outcome of end-stage hypertrophic cardiomyopathy: a case report [J ] . Ann Noninvasive Electrocardiol , 2025 , 30 ( 3 ): e70073 .
Wojtkowska A , Zarczuk R , Brzozowski W , et al . 113 Echocardiographic assessment of right ventricular outflow tract obstruction in hypertrophic cardiomyopathy-efficacy of dual chamber pacing in reducing of gradient [J ] . Eur Heart J Cardiovasc Imag , 2020 , 21 ( Supplement_1 ):jez319.029.
Veselka J , Hansvenclova E , Tesarkova KH , et al . Comparable outcomes in single versus multiple septal branches alcohol ablation for obstructive hypertrophic cardiomyopathy [J ] . Int J Cardiol , 2025 , 429 : 133145 .
Matsuda J , Tokita Y , Hoshika L , et al . Optimal ablation pattern on intraprocedural echocardiography is associated with favorable clinical outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy [J ] . J Cardiol , 2025 , 86 ( 1 ): 64 - 72 .
Sato R , Sakamoto A , Suwa K , et al . Alcohol septal ablation in drug-refractory hypertrophic obstructive cardiomyopathy patient with multiple comorbidities [J ] . J Cardiol Cases , 2025 , 31 ( 1 ): 5 - 8 .
廖福顺 , 游宇光 . 经皮心肌内室间隔射频消融治疗肥厚型梗阻性心肌病进展 [J ] . 中国介入影像与治疗学 , 2024 , 21 ( 4 ): 247 - 251 .
Liao FS , You YG . Progresses of percutaneous intramyocardial septal radiofrequency ablation of hypertrophic obstructive cardiomyopathy [J ] . Chin J Interv Imag Ther , 2024 , 21 ( 4 ): 247 - 251 .
Wasserstrum Y , Barbarova I , Lotan D , et al . Efficacy and safety of exercise rehabilitation in patients with hypertrophic cardiomyopathy [J ] . J Cardiol , 2019 , 74 ( 5 ): 466 - 472 .
Li M , Zhuo XJ , Shao LH , et al . The effect of cardiac rehabilitation prescription on medication complications and ET-1,WMSI in elderly patients with coronary heart disease [J ] . J Cardiothorac Surg , 2024 , 19 ( 1 ): 630 .
邢坤权 . 运动训练对血脂代谢影响的研究进展 [J ] . 当代体育科技 , 2021 , 11 ( 32 ): 40 - 43 .
Xing KQ . Research progress of the effect of exercise training on lipid metabolism [J ] . Contemp Phys Technol , 2021 , 11 ( 32 ): 40 - 43 .
de Almeida JA , Batalha APDB , de Oliveira Santos CV , et al . Acute effect of aerobic and resistance exercise on glycemia in individuals with type 2 diabetes: Systematic review and meta-analysis [J ] . Braz J Phys Ther , 2025 , 29 ( 1 ): 101146 .
Baral R , Ho JSY , Soroya AN , et al . Exercise training improves exercise capacity and quality of life in heart failure with preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials [J ] . Eur Heart J Open , 2024 , 4 ( 4 ): oeae033 .
Kim T , Jin Y , Cho J , et al . Impact of exercise training on survival rate and neural cell death in sepsis through the maintenance of redox equilibrium [J ] . Int Neurourol J , 2024 , 28 ( 1 ): 22 - 32 .
Ommen SR , Mital S , Burke MA , et al . 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines [J ] . J Am Coll Cardiol , 2020 , 76 ( 25 ): 3022 - 3055 .
Kambič T , Feuerstein A , Tran PT , et al . Exercise training in left ventricular assist device patients: Protocol of an individual participant data meta-analysis [J ] . ESC Heart Fail , 2025 , 12 ( 1 ): 649 - 656 .
Hegde SM , Lester SJ , Solomon SD , et al . Effect of mavacamten on echocardiographic features in symptomatic patients with obstructive hypertrophic cardiomyopathy [J ] . J Am Coll Cardiol , 2021 , 78 ( 25 ): 2518 - 2532 .
Olivotto I , Oreziak A , Barriales-Villa R , et al . Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM):a randomised,double-blind,placebo-controlled,phase 3 trial [J ] . Lancet , 2020 , 396 ( 10253 ): 759 - 769 .
Alghadir AH , Gabr SA , Iqbal A . Enhancing cognitive performance and mitigating dyslipidemia: the impact of moderate aerobic training on sedentary older adults [J ] . BMC Geriatr , 2024 , 24 ( 1 ): 678 .
Schumann CL , Nealy ZB , Mathew RC , et al . Pilot study of supervised exercise and intensive medical therapy in patients with ischemia with No evidence of obstructive coronary artery disease and coronary microvascular dysfunction [J ] . Am J Cardiol , 2024 , 214 : 142 - 143 .
Fonseca EG , Araújo-Ferreira AP , Berger M , et al . Preconditioning by moderate-intensity exercise prevents gentamicin-induced acute kidney injury [J ] . Int J Sports Med , 2024 , 45 ( 12 ): 884 - 896 .
Basu J , Malhotra A , Papadakis M . Exercise and hypertrophic cardiomyopathy: Two incompatible entities? [J ] . Clin Cardiol , 2020 , 43 ( 8 ): 889 - 896 .
Pelliccia A , Solberg EE , Papadakis M , et al . Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies,myocarditis,and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology(EAPC) [J ] . Eur Heart J , 2019 , 40 ( 1 ): 19 - 33 .
Kantenwein V , Pavaci H , Haller B , et al . Ventricular arrhythmias and the role of antitachycardia pacing in patients with electrical heart disease and hypertrophic cardiomyopathy [J ] . Int J Cardiol Congenit Heart Dis , 2025 , 19 : 100562 .
Verma A , Anand A , Patel VA , et al . Redefining management in hypertrophic cardiomyopathy: the role and challenges of exercise rehabilitation [J ] . Cardiol Rev , 2024 .
胡小莹 , 乔树宾 , 孙兴国 , 等 . 肥厚型心肌病患者的心肺功能评估和相关因素研究 [J ] . 中国循环杂志 , 2021 , 36 ( 4 ): 372 - 378 .
Hu XY , Qiao SB , Sun XG , et al . Assessment of cardiopulmonary exercise capacity in patients with hypertrophic cardiomyopathy [J ] . Chin Circ J , 2021 , 36 ( 4 ): 372 - 378 .
中国康复医学会心血管病专业委员会 . 中国心脏康复与二级预防指南: 2018版 [M ] . 北京 : 北京大学医学出版社 , 2018 .
Cardiovascular disease professional committee of the chinese association of rehabilitation medicine . Chinese guideline for cardiac rehabilitation and secondary prevention [M ] . Beijing : Peking University Medical Press , 2018 .
Sharma S , Pelliccia A , Gati S . The ‘ten commandments’ for the 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease [J ] . Eur Heart J , 2020 :ehaa735.
Toval A , Solis-Urra P , Bakker EA , et al . Exercise and brain health in patients with coronary artery disease:study protocol for the HEART-BRAIN randomized controlled trial [J ] . Front Aging Neurosci , 2024 , 16 : 1437567 .
Bozkurt B , Fonarow GC , Goldberg LR , et al . Cardiac rehabilitation for patients with heart failure: JACC expert panel [J ] . J Am Coll Cardiol , 2021 , 77 ( 11 ): 1454 - 1469 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621